) is raised by 10%, the CaSR-mediated reduction in P Ca TAL per se is predicted to enhance urinary Ca 2ϩ excretion by ϳ30%. If high [Ca 2ϩ ] also induces renal outer medullary potassium (ROMK) inhibition, urinary Ca 2ϩ excretion is further raised. In vitro, increases in luminal [Ca 2ϩ ] have been shown to activate H ϩ -ATPase pumps in the outer medullary CD and to lower the water permeability of IMCD. Our model suggests that if these responses exhibit the sigmoidal dependence on luminal [Ca 2ϩ ] that is characteristic of CaSR, then the impact of elevated Ca 2ϩ levels in the CD on urinary volume and pH remains limited. Finally, our model suggests that CaSR inhibitors could significantly reduce urinary Ca 2ϩ excretion in hypoparathyroidism, thereby reducing the risk of calcium stone formation. calcium; transport; epithelium; CaSR; mathematical model THE PLASMA CONCENTRATION OF calcium must remain within tight bounds to ensure that Ca 2ϩ can fulfill its multiple extra-and intracellular roles. Ca 2ϩ homeostasis is regulated principally by four tissues: the intestine and kidney determine how much Ca 2ϩ is absorbed and excreted by the body; bones constitute the main Ca 2ϩ repository and can act as a rapid storage/release compartment; and parathyroid glands secrete the parathyroid hormone (PTH), which regulates Ca 2ϩ fluxes between these different compartments and plasma.
The kidney normally excretes only a small fraction (ϳ1-2%) of filtered Ca 2ϩ . Along the nephron, Ca 2ϩ is passively reabsorbed across the paracellular route in the proximal tubule (PT) and the thick ascending limb (TAL) and actively reabsorbed across epithelial cells in the distal convoluted (DCT) and connecting (CNT) tubules (19) . PTH stimulates Ca 2ϩ reabsorption in different segments of the nephron. In the TAL, PTH appears to increase the paracellular permeability to Ca 2ϩ (39, 64) . In the CNT, PTH induces a coordinated increase in the expression of transcellular Ca 2ϩ transport proteins, namely, the transient receptor potential channel vanilloid subtype 5 (TRPV5), the Na ϩ /Ca 2ϩ exchanger NCX1, and calbindin-D 28K (57) .
The secretion of PTH into plasma is in turn modulated by the calcium-sensing receptor (CaSR), via a negative feedback mechanism. CaSR is expressed in several tissues other than the parathyroid gland, including the kidney (47) . A recent study indicates that the renal CaSR can directly modulate Ca 2ϩ reabsorption, independently of PTH (39) .
The specific localization of CaSR in the rat kidney remains partly controversial (59) . Some investigators have detected CaSR at the basolateral membrane of PT, TAL, and DCT-CNT cells and at the apical membrane of collecting duct (CD) cells (48) , whereas others have found it in the TAL only (39, 52) . The functions of CaSR have not been fully elucidated either. Inactivation of CaSR has recently been shown to increase the TAL paracellular permeability to Ca 2ϩ (39) ; some studies, but not others, suggest that CaSR also modulates the reabsorption of NaCl and K ϩ in that segment, as discussed below. In the PT, CaSR is thought to stimulate the luminal Na ϩ /H ϩ exchanger, thereby increasing tubular fluid reabsorption and urinary acidification (14) . In the CD, calcium-sensing mechanisms reduce the vasopressin-induced expression of aquaporin-2 (AQP2) and promote polyuria (13, 50) ; they also stimulate proton secretion via H ϩ -ATPase pumps, thereby acidifying urine (46) . Both processes are thought to help reduce Ca 2ϩ precipitation in the CD.
The effects of the calcium-sensing mechanisms described above were mostly investigated on isolated cells and tubules. To obtain an integrated and quantitative assessment of the impact these regulatory mechanisms may have on renal Ca 2ϩ handling and urinary Ca 2ϩ excretion, we expanded a mathematical model of the rat nephron, from the TAL to the inner medullary collecting duct (IMCD), to include Ca 2ϩ transport.
MODEL DESCRIPTION
The mathematical model describes the transepithelial exchanges of water and solutes, including Ca 2ϩ , along one representative population of nephrons, extending from the medullary thick ascending limb (mTAL) to the IMCD. It represents the epithelial barrier explicitly, i.e., it accounts for the apical and basolateral transporters that are specific to each type of cell. The present model builds upon 2 previous models: that of Weinstein (61) , which considered the transport from the TAL to the IMCD of water and 12 solutes but not that of Ca 2ϩ ; and our previous cell-based model of Ca 2ϩ transport along the DCT2-CNT (8) . Modifications to these two models are described in the APPENDIX.
Volume flows (or volumes), concentrations, and electric potentials in the tubular lumen and epithelial cells are determined by solving conservation equations for volume, mass, and charge, respectively (8, 61) . Briefly, at steady state, spatial variations in the molar flow of Ca 2ϩ in the tubular lumen (subscript "L") are given by:
where F V is the luminal volume flow, [Ca 2ϩ ] denotes the concentration of Ca 2ϩ , T trans and T para denote the surface area per unit length of the transcellular and paracellular pathways, respectively, and J Ca trans and J Ca para are the transcellular and paracellular Ca 2ϩ fluxes. The paracellular flux is calculated as:
The subscript "LIS" denotes the lateral intercellular space (the composition of which is close to that of the interstitium), PCa is the paracellular permeability of the tubule to Ca 2ϩ , and Ca is a nondimensional electric potential difference:
where ⌿ i is the electric potential of compartment i, zCa is the valence of Ca 2ϩ , F is Faraday's constant, R is the ideal gas constant, and T is the temperature. Transcellular Ca 2ϩ fluxes are determined as described in Ref. 8 .
Calcium transport parameters. The paracellular permeability of the cortical thick ascending limb (cTAL) to Ca 2ϩ is taken as 8.4 ϫ 10
Ϫ5
cm/s (45) . Transepithelial Ca 2ϩ fluxes across the mTAL are small in the absence of bicarbonate. However, in the presence of HCO 3 Ϫ (i.e., under more physiological conditions), Wittner et al. (63) observed substantial Ca 2ϩ reabsorption in the mTAL. Based on their study, we estimate the Ca 2ϩ permeability of the mTAL to be half that of the cTAL.
We assume that the paracellular permeability to Ca 2ϩ is negligible in the DCT-CNT, and equal to 0.14 ϫ 10 Ϫ6 cm/s in the CD, as measured in the rabbit cortical CD (CCD) (11) . The permeability of the basement membrane (at the interface between the lateral space between cells and the peritubular fluid) to a given solute is taken to be proportional to the solute's diffusivity in free solution. The permeability of the basement membrane to Ca 2ϩ is, therefore, calculated based on that to Na ϩ , assuming a Ca 2ϩ -to-Na ϩ free diffusivity ratio of 7.93/13.3 (37) .
The density and kinetic properties of Ca 2ϩ transport proteins in the DCT2-CNT are identical to those used in our previous model (8) . Some studies have suggested that the IMCD may actively reabsorb Ca 2ϩ (5, 40) , but the underlying mechanisms/transporters remain to be identified, as discussed below. We assume no active reabsorption of Ca 2ϩ in the IMCD in this model. Peritubular and inlet Ca 2ϩ concentrations. We recently built a "macroscopic" model of calcium transport in different populations of nephrons, vasa recta, and the interstitium (54) . In contrast with the current model, the macroscopic model did not represent the epithelial barrier at the cellular level, but it computed interstitial concentrations. In particular, it predicted a significant interstitial Ca 2ϩ concentration gradient along the cortico-medullary axis. Based on these results, we assume that interstitial [Ca 2ϩ ] increases linearly from 1.25 mM at the cortico-medullary junction to 2.50 mM at the outer-inner medullary junction, and therefrom to 4 mM at the papillary tip.
At the mTAL inlet, the luminal [Ca 2ϩ ] is taken as 3.75 mM and the volume flow is set to 6 nl/min. With these assumptions, the Ca 2ϩ load delivered to the mTAL is 3.75 ϫ 6 ϭ 22.5 pmol·min Ϫ1 ·nephron Ϫ1 or 1.35 mol/min assuming a total of 60,000 nephrons in the rat (6).
This represents 40% of the filtered load, if the latter is taken as 3.4 mol/min (55) .
In the isolated cTAL simulations below, the composition of the cortical interstitium is as follows (in mM): 144. (39) . We used the data of Wittner et al. (64) to estimate the quantitative impact of luminal PTH on P Ca TAL . In the absence of active NaCl transport in the TAL, the addition of PTH (10 Ϫ8 M) to the bath raised P Ca TAL by 30 -40%. In parathyroidectomized (PTX) rats, protein expression levels of TRPV5 and calbindin-D28K were found to be, respectively, ϳ80 and 20% lower than in control rats, and mRNA levels of NCX1 were ϳ20% lower (57) .
Calcium-sensing mechanisms. The relationship between extracellular calcium and PTH release is a steep inverse sigmoidal curve. The impact of CaSR on a given variable is therefore represented by a sigmoidal function: ]L is raised from 0.1 to 5 mM. Numerical method. The conservation equations for water and solutes along the nephron and within epithelial cells are solved at steady state. Each nephron segment is discretized (with 100 grid points/mm), and spatial derivatives in the lumen are approximated by a first-order centered difference scheme. At each position along the tubule, the system of coupled, nonlinear algebraic conservation equations is solved using Newton's method. Calculations are performed using a Fortran program that is executed in double precision.
RESULTS

Calcium transport in the TAL.
Ca 2ϩ reabsorption in the TAL is a paracellular process, driven by the lumen-positive transepithelial electric potential difference (⌬V te ) that results from the transcellular reabsorption of NaCl in parallel with the apical recycling of K ϩ . We first considered Ca 2ϩ transport in an isolated cTAL and examined the impact of changes in NaCl and KCl concentrations on Ca 2ϩ fluxes (J Ca ). The composition of the bath was taken to be identical as that of the cortical interstitium. Figure 1 illustrates the effects of varying NaCl concentration ([NaCl]) in the perfused solution. As luminal [NaCl] is reduced, the paracellular reabsorption of Na ϩ decreases, and the transepithelial voltage increases, which in turn enhances J Ca . These predictions are in accordance with microperfusion experiment results in rabbits and rats (10, 41) . Of note, our results suggest that ⌬V te , and thus J Ca , are highly sensitive to the concentration of ammonia. Indeed, NH 4 ϩ is thought to play a catalytic role in NaCl reabsorption in the TAL, through a cycle of uptake via the TAL Na
Ϫ cotransporter NKCC2 and backflux as NH 4 ϩ and NH 3 (61) . As in the study of Weinstein (61) ]. Note first that per se, an increase in F v decreases the rate at which luminal concentrations vary. In other words, all else being constant, the higher F v is, the less luminal [Ca 2ϩ ] falls. This reduces the transepithelial Ca 2ϩ concentration gradient and enhances Ca 2ϩ reabsorption. Countering this, however, is the volume flow-induced decrease in ⌬V te , which slows down Ca 2ϩ reabsorption. With 0.1 mM ammonia, the former effect predominates, i.e., J Ca is predicted to increase with increasing F v , as depicted in Fig. 3 . With 1.0 mM ammonia, the later effect prevails at high volume flows, such that J Ca is predicted to slightly diminish as F v increases from 6 to 8 nl/min.
We then examined the impact of changes in Ca 2ϩ concentration on Na ϩ and K ϩ transport in the TAL under three scenarios: we assumed that CaSR alters the paracellular permeability of Ca 2ϩ only (case 1), that of Ca 2ϩ and Na ϩ (case 2), or that of all cations (case 3). Shown in Fig. 4 are predicted values of cTAL Na (Fig. 4) . Calcium transport along the full distal nephron. The determinants of Ca 2ϩ fluxes in the DCT2-CNT were investigated in our previous study (8) . Thus we next simulated the in vivo transport of Ca 2ϩ along the full distal nephron. Shown in Table 1 are model results for normal (base case) conditions. The model predicts that the TAL and DCT2-CNT, respectively, reabsorb 25 and 12% of the filtered load of calcium, in good agreement with experimental findings (9, 22 We also validated the model by comparing its predictions to experimental data under other conditions. Studies suggest that urinary Ca 2ϩ excretion increases by a factor of 5-9 following the acute administration of furosemide (23, 36) and by a factor of 6 in TRPV5 knockout mice (28) . Our model adequately reproduces these findings, as shown in Table 1 . It predicts that furosemide, which inhibits NKCC2, decreases Ca 2ϩ reabsorption not only in the TAL but also in the DCT2-CNT. In the TAL, NKCC2 inhibition abolishes the lumen-positive transepithelial voltage that drives the paracellular reabsorption of Ca 2ϩ under normal conditions. In the DCT2-CNT, our results suggest that the furosemideinduced increase in the delivered load of Na ϩ stimulates Na ϩ reabsorption, raises intracellular Na ϩ concentrations in principal cells, and thereby downregulates the Na ϩ /Ca ϩ exchanger NCX1, which in turn reduces basolateral Ca 2ϩ extrusion, as previously described (8) .
Calcium transport perturbations. To assess the impact of segment-specific Ca 2ϩ transport perturbations on urinary Ca 2ϩ excretion, we first simulated a 50% decrease in the TAL permeability to Ca 2ϩ (P Ca TAL ). As shown in Fig. 6 , the DCT-CNT cannot compensate for reduced reabsorption in the TAL; by itself, the increase in [Ca 2ϩ ] L is not sufficient to strongly stimulate transport across TRPV5. As a result, the urinary excretion of Ca 2ϩ (UV Ca ) is predicted to increase almost fourfold.
In the DCT2-CNT, the basolateral extrusion of Ca 2ϩ occurs predominantly (ϳ70%) via NCX1; the remainder is carried out by the plasma membrane Ca 2ϩ pump PMCA (7). With full inhibition of NCX1, Ca 2ϩ reabsorption along the DCT2-CNT is predicted to decrease by 60%, that is, PMCA scarcely compensates for the absence of the other basolateral efflux pathway (Fig. 6) . Numerical results are summarized in Table 1 . . In those studies where it was measured, the glomerular filtration rate (GFR) was also reduced (32, 56) . To assess the quantitative impact of PTH on renal Ca 2ϩ handling, we examined several scenarios. PTX was simulated by reducing the basal TAL permeability to Ca 2ϩ by 35% and decreasing the expression of TRPV5 and NCX1 by 80% each (see MODEL DESCRIPTION). In case A, GFR and plasma and interstitial Ca 2ϩ levels were maintained at their base-case values. In case B, plasma and interstitial Ca 2ϩ levels were lowered by 30%. In case C, GFR and Ca 2ϩ levels were reduced by 30%. Results are shown in Table 2 .
Regulation by PTH.
As expected, in all cases the predicted rate of Ca 2ϩ reabsorption (in mol/min) along the TAL and DCT2-CNT decreased significantly, by 20 to 45% in the TAL, and by 70% in the DCT2-CNT (PTX vs. normal rats). In cases A and B, that decrease was greater than the reduction in the calcium load delivered to the TAL, and UV Ca was higher than in the control case. In case C, by contrast, the reduction in the TAL Ca 2ϩ load was greater than the decrease in Ca 2ϩ reabsorption downstream, and UV Ca was lower than in the control case.
Conversely, assuming that elevated PTH levels increase the TAL permeability to Ca 2ϩ and the expression of TRPV5 and NCX1 by 10% each, Ca 2ϩ reabsorption along the nephron is predicted to increase by about 5-10%. However, UV Ca may increase in tandem if Ca 2ϩ delivery to the TAL is concomitantly raised (Table 2) . According to our model, in rats with high PTH levels, the fractional reabsorption of Ca 2ϩ in the TAL remains approximately constant as the Ca 2ϩ load delivered to the TAL is varied. In contrast, in PTX rats, fractional reabsorption decreases with increasing load.
Taken together, these results suggest that the impact of PTH on net Ca 2ϩ excretion depends on the extent to which the filtered load of Ca 2ϩ also varies. Note that the latter is in turn a function of Ca 2ϩ excretion, as discussed below. Calcium-sensing mechanisms in the TAL. In all the simulations presented below, PTH levels were taken to be "clamped" to isolate the effects of calcium-sensing mechanisms. We examined the impact of the CaSR-induced reduction in the TAL permeability to Ca 2ϩ under two scenarios. First, hypercalcemia was simulated by increasing [Ca 2ϩ ] by 10% everywhere in the interstitium and in the tubular fluid at the mTAL inlet. Relative to the control case, the TAL then reabsorbed more Ca 2ϩ , but the increase was attenuated by the CaSRinduced decrease in P Ca TAL ; without these effects, the predicted UV Ca would have been 23% lower (Fig. 7) . In the opposite scenario, namely a 10% decrease in interstitial and mTAL inlet [Ca 2ϩ ] to simulate hypocalcemia, the predicted UV Ca would have been 54% higher without CaSR effects (Table 3) . These results suggest that the TAL CaSR can substantially modulate renal Ca 2ϩ excretion. Some investigators, but not others, have found that CaSR also regulates the transport of NaCl in the TAL (see DISCUS-SION). It has been proposed that CaSR activation during hypercalcemia inhibits renal outer medullary potassium (ROMK) channels, thereby dissipating the lumen-positive transepithelial voltage and reducing Ca 2ϩ reabsorption (47) . To probe this scenario, in the next set of simulations we assumed that in hypercalcemic rats, the permeability of ROMK in the TAL varies with peritubular Ca 2ϩ concentration as described by Eq. 4. The parameter ␣ ROMK , which characterizes the strength of , and after acute administration of furosemide (dashed lines). In the latter simulations, we assume that interstitial concentration gradients along the cortico-medullary axis are entirely abolished and that the Na ϩ -K ϩ -2Cl Ϫ cotransporter NKCC2 is inhibited by 99.9%. The abscissa (x) represents the distance from the medullary thick ascending limb (mTAL) to the inner medullary collecting duct (IMCD). The mTAL spans the distance between x ϭ 0 and 0.2 cm, the cTAL that between 0.2 and 0.4 cm, the distal convoluted tubule (DCT) that between 0.4 and 0.5 cm, the connecting tubule (CNT) that between 0.5 and 0.7 cm, the cortical CD (CCD) that between 0.7 and 0.9 cm, the outer medullary CD (OMCD) that between 0.9 and 1.1 cm, and the IMCD that between 1.1 and 1.6 cm. The dotted vertical lines indicate the cortico-medullary junction (mTAL-cTAL and CCD-OMCD boundaries) and the outer-inner medullary junction (OMCD-IMCD boundary). this regulation, was taken as 1 in these simulations, so that CaSR activation reduced the ROMK permeability by a factor of ϳ2 in the cortex.
Under hypercalcemic conditions (simulated as described above), the model predicts that CaSR-mediated inhibition of ROMK would decrease the length-averaged ⌬V te by 65% in the mTAL and 6% in the cTAL and would thereby reduce Ca 2ϩ reabsorption in these segments; the predicted UV Ca would then be 20% higher than in the absence of CaSR effects on ROMK (Table 3 and Fig. 7) . Our results also suggest that CaSR-mediated ROMK inhibition in the TAL would increase urinary K ϩ excretion (by 13% with ␣ ROMK set to 1): the model predicts that increased K ϩ reabsorption in the TAL is overcompensated for by increased K ϩ secretion downstream. In the remaining simulations, ␣ ROMK was set to zero.
Calcium-sensing mechanisms in the CD. We assessed the impact of modulation of AQP2 expression in the IMCD by high luminal [Ca 2ϩ ] under two scenarios: when the TAL permeability to calcium is halved or when TRPV5 is fully inhibited (see Table 1 ). With a half-maximum concentration (EC 50 ) of 1.25 mM and a Hill coefficient (n) of 4, regulation of AQP2 expression by luminal [Ca 2ϩ ] is predicted to reduce water reabsorption along the IMCD by about 12%, and the urinary concentration of Ca 2ϩ by 1 to 2 mM, as shown in Fig. 8 . Increasing EC 50 by a factor of 10 and varying n between 0.5 and 8 yields very similar results. Assuming that luminal Ca 2ϩ regulates the apical water permeability of principal cells not only in the IMCD but also in the CCD and OMCD does not result in significantly greater effects.
We also examined whether modulation of H ϩ -ATPase fluxes by luminal [Ca 2ϩ ] in the OMCD substantially affects luminal pH, under the same set of conditions as above. As illustrated in Fig. 9 , or full inhibition of TRPV5; in all cases, the volume flow at the mTAL inlet was kept constant. We found that the renal excretion of at least one of these four solutes differed by Ͼ5% from base case values in two scenarios only, namely, TRPV5 inhibition and PTX (Fig. 10) . Note , and NH 4 ϩ was, respectively, 8, 10, 11, and 1% lower than in the base case. These variations stem mostly from increased Na ϩ reabsorption and decreased K ϩ secretion in the DCT and CNT. Indeed, in both scenarios, Ca 2ϩ reabsorption in the DCT2-CNT is significantly reduced or entirely abolished; the subsequent downregulation of NCX1 lowers intracellular Na ϩ concentrations, which 1) stimulates the apical entry of Na ϩ into the cell, thereby enhancing Na ϩ reabsorption; and 2) downregulates Na-K-ATPase pumps, thereby reducing K ϩ secretion. The latter is only partially compensated for by a decrease in K ϩ reabsorption in the CD.
When we performed the same set of simulations assuming that CaSR alters the paracellular permeability of the TAL to all cations (i.e., not only that to Ca 2ϩ ), we obtained similar results. The renal excretion of Na ϩ , K ϩ , HCO 3 Ϫ , and NH 4 ϩ differed by Ͼ5% from control values in the same 2 scenarios, TRPV5 inhibition and PTX, and trends were then quantitatively comparable.
Lastly, we computed tubular fluid-to-ultrafilterable ratios (TF/UF) along the distal nephron and plotted the Ca 2ϩ -to-Na ϩ TF/UF ratio as a function of position under different conditions, as depicted in Fig. 11 . These predictions were compared with the micropuncture data summarized in Sutton and Dirks (51) . In our model, the base-case Ca 2ϩ -to-Na ϩ TF/UF ratio increases from 1.75 to 3.1 along the TAL, drops to ϳ1.1 in the cortical distal tubule, remains constant in the CCD and OMCD, and rises along the IMCD to a value of 2 in urine. Our theoretical prediction for the distal tubule is very close to the experimental values obtained by LeGrimellec et al. (34, 35) . Experimental values of the Ca 2ϩ -to-Na ϩ TF/UF ratio in urine vary widely, from Ͻ0.4 to Ͼ4 (31, 34, 35, 44) ; our predicted value is contained within this large interval.
Under hypercalcemic conditions (simulated by raising filtered and interstitial [Ca 2ϩ ] by 10%), the Ca 2ϩ -to-Na ϩ TF/UF ratio is predicted to increase significantly, as Ca 2ϩ reabsorption is reduced. Our computed value in the early distal tubule (1.9) is higher than the value (1.4) reported by LeGrimellec et al. (35) ] by 10%), the computed Ca 2ϩ -to-Na ϩ TF/UF ratio is predicted to decrease, since Ca 2ϩ reabsorption is augmented (Fig. 11) . In the presence of furosemide, the ratio is predicted to remain constant along the distal nephron, as observed in dogs (51) .
DISCUSSION
The present model was developed to investigate the impact of calcium-sensing mechanisms in renal tubules. It is the first detailed, epithelial-based model of Ca 2ϩ transport along the TAL and the distal nephron. It reproduces a number of experimental findings, such as measurements of luminal Ca 2ϩ concentrations in cortical tubules, and the impact of furosemide or TRPV5 deletion on urinary Ca 2ϩ excretion. We should nevertheless acknowledge some of its limitations. We consider one representative nephron, without distinguishing between superficial and juxta-medullary nephrons, when in fact luminal concentrations at the mTAL inlet are predicted to vary significantly with the length of Henle's loop (33, 42, 54) . Because the model does not take into consideration the complex architecture of the medulla and the role of vasa recta, it assumes fixed interstitial concentration gradients along the corticomedullary axis, following the approach of Weinstein (61); we did, however, abolish these gradients in the furosemide simulations. In addition, our model does not account for the binding of Ca 2ϩ to ions such as bicarbonate, phosphate, and oxalate. In plasma, the amount of complexed calcium is ϳ10 times lower than that of ionized calcium (62) . The model will have to be expanded to incorporate those calcium complexes, as well as to include the effects of 1,25-dihydroxyvitamine D 3 .
Our results suggest that segment-specific Ca 2ϩ transport defects are scarcely compensated for downstream. A twofold decrease in the TAL permeability to Ca 2ϩ is predicted to raise urinary Ca 2ϩ excretion almost fourfold (Table 1) , because it is not counterbalanced by a significant increase in reabsorption in distal segments: TRPV5 is not sufficiently upregulated, and transepithelial Ca 2ϩ exchanges in the CD are small. Topala et al. (53) reported that CaSR and TRPV5 colocalize at the luminal membrane of human DCT/CNT and demonstrated that CaSR activates TRPV5 when both are expressed in HEK293 cells. Miller and colleagues (15, 30) also found that CaSR decreases the cell surface expression of Kir4.1 channels when both are expressed in heterologous systems. Since no such colocalization and interactions have been reported in rat DCT/ CNT, they were not included in this model. We also did not consider active Ca 2ϩ reabsorption in the CD, as it remains poorly understood and is not thought to be very significant. The CD reabsorbs at most 3% of filtered load of Ca 2ϩ (27) . Its precise contribution is difficult to assess, partly because only portions of the distal nephron are accessible to micropuncture (25) ; estimates of the proportion of the Ca 2ϩ load delivered to the CD that is reabsorbed along this segment vary from 0 to 95% (1, 5, 25) . Furthermore, the underlying mechanisms are unknown. Passive transport in the CD favors Ca 2ϩ secretion (ϳ0.03% of the filtered load, according to our model), so reabsorption must be an active process. The CD expresses the Ca 2ϩ channel TRPV6 on the apical membrane of principal cells but not the basolateral Ca 2ϩ extrusion proteins NCX1 and PMCA (43) . Even though the model does not account for active Ca 2ϩ transport in the CD, the fact that it accurately replicates the experimental observation that administration of furosemide and TRPV5 deletion each raise urinary Ca 2ϩ excretion more than fivefold strongly suggests that there is indeed very little compensation in the DCT-CNT and the CD.
Another reason why the contribution of the CD to Ca 2ϩ transport is difficult to determine experimentally has to do with the heterogeneity of tubular transport capacity. Calcium reabsorption profiles differ significantly between superficial and juxta-medullary nephrons (which merge in the CD system), as previously recognized (1, 25) and as confirmed by our recent macroscopic model of Ca 2ϩ transport in different populations of nephrons and vasa recta (54) . That model did not explicitly incorporate apical and basolateral transporters, instead it assumed segment-specific Ca 2ϩ permeability values and prescribed the transepithelial voltage along the nephrons. Within those constraints, the macroscopic model predicted that juxtamedullary nephrons overall reabsorb more Ca 2ϩ (and deliver less Ca 2ϩ to the CD) than superficial nephrons do. However, between the TAL and the CD, juxta-medullary nephrons were found to reabsorb less Ca 2ϩ , relative to superficial nephrons. The present model, which is based on a different approach and does not fix a priori ⌬V te , can also be used to probe these differences. As shown in Figs. 1 and 3 , the model predicts that in the TAL, J Ca rises as the bath-to-lumen [NaCl] gradient increases but it is relatively insensitive to luminal volume flow (assuming physiological concentrations of ammonia). To the extent that interstitial-to-lumen [NaCl] gradients are larger in superficial TALs than in juxta-medullary TALs (33), these results suggest that transepithelial Ca 2ϩ fluxes are also greater in superficial TALs. Expanding the current model to account for different populations of nephrons could shed some light on the quantitative impact of this heterogeneity and on the contribution of the CD to renal Ca 2ϩ handling. PTH has been shown to increase the expression of TRPV5 and NCX1 in rabbit CNT/CCD cell cultures (57) ; in the cTAL, it most likely acts by raising the paracellular permeability to Ca 2ϩ , P Ca TAL , as suggested by in vitro microperfusion studies in rats (39) and mice (64) . Our model predicts that these "direct" effects have a significant impact on the renal handling of Ca 2ϩ ; in their absence, Ca 2ϩ reabsorption would be ϳ20 and 75% lower in the TAL and DCT2-CNT, respectively, which per se would increase urinary Ca 2ϩ excretion sixfold (Table 2 ). These direct effects cannot be considered in isolation, however: an increase in Ca 2ϩ reabsorption subsequently raises the plasma concentration and the filtered load of Ca 2ϩ , which in turn affects the rate of PTH release and renal Ca 2ϩ transport. A dynamic model that includes the main organs involved in Ca 2ϩ homeostasis (the kidney, bone, intestine, and parathyroid glands) is needed to investigate these feedback mechanisms.
In vitro microperfusion of rat TAL has demonstrated that activation of CaSR lowers the TAL permeability to Ca 2ϩ (39) . Our results suggest that this regulatory mechanism has a significant impact on renal Ca 2ϩ handling: when plasma [Ca 2ϩ ] is raised by 10%, per se the CaSR-mediated reduction in P Ca TAL is predicted to enhance urinary Ca 2ϩ excretion by ϳ30% (Fig. 3) (60) found that raising extracellular Ca 2ϩ reduces the activity of apical K ϩ (ROMK) channels in the TAL. The inhibition of ROMK should in turn decrease transport across NKCC2 and reduce the lumen-positive ⌬V te , ultimately lowering the transcellular reabsorption of Ca 2ϩ . In support of this "indirect" mechanism, some investigators reported that raising basolateral Ca 2ϩ or adding neomycin reduces transepithelial Cl Ϫ transport across microperfused rat cTAL (17) . Others, however, saw no change in NaCl fluxes following an increase in basolateral Ca 2ϩ (18) or addition of the CaSR-specific inhibitor NPS2143 (39) . Our model suggests that CaSR-induced inhibition of ROMK, if it occurs, can indeed further enhance urinary Ca 2ϩ excretion in hypercalciuria according to the mechanism proposed above (Fig. 7) . The model cannot, however, confirm or disprove the validity of this hypothesis.
There is another potential mechanism by which CaSR may affect the TAL transport of solutes other than Ca 2ϩ . CaSR is thought to modulate the permeability of the tight junction, which is regulated by claudins. Mutations in the gene encoding claudin 16 result in familial hypomagnesemic hypercalciuric nephrocalcinosis (FHHNC), a disease characterized by severe defects in Ca 2ϩ and Mg 2ϩ reabsorption in the TAL (29) . These findings suggest that claudin 16 acts as a Ca 2ϩ and Mg 2ϩ pore, perhaps in conjunction with claudin 19. As recently reviewed, some studies indicate that claudin 16 augments the Ca 2ϩ -toNa ϩ paracellular permeability ratio (P Ca /P Na ), whereas other results suggest that claudin 16 increases P Na (29) . In the base case, we assumed that CaSR modulates solely the TAL permeability of Ca 2ϩ , but in a separate set of simulations we examined the possibility that it also regulates that of Na ϩ and other cations. Under normocalcemic conditions, the molar flow profiles of Na ] had only a small (Ͻ 5%) impact on Na ϩ and K ϩ reabsorption in the TAL, as illustrated in Fig. 4 . Together these results suggest that if CaSR modulates the TAL paracellular permeability of other cations to the same extent as that of Ca 2ϩ , this regulatory mechanism does not significantly affect the renal handling of other solutes. It does, however, amplify the dynamic range of regulation of urinary Ca 2ϩ excretion, owing to its impact on ⌬V te (Fig. 4) .
Increasing luminal [Ca 2ϩ ] lowers the water permeability of IMCD in vitro (50) , and the subsequent increase in tubular volume flow is thought to help lower the urinary concentration of Ca 2ϩ and forestall crystallization. According to our model, if P f displays a sigmoidal dependence on luminal [Ca 2ϩ ] in the IMCD as described by Eq. 4, the impact of elevated IMCD Ca 2ϩ levels remains limited: the resulting P f decrease in this segment reduces urinary [Ca 2ϩ ] by 2 mM at most (Fig. 8) . To produce larger effects, the sensitivity of P f to large variations in luminal [Ca 2ϩ ] would have to be substantially greater.
Increasing luminal [Ca 2ϩ ] also stimulates H ϩ -ATPase activity in dissected mouse OMCD. Moreover, urinary pH is ϳ1.5 units lower in TRPV5 Ϫ/Ϫ mice than in control mice; ablation of the (CD-specific) B1 subunit of the H ϩ -ATPase in TRPV5
Ϫ/Ϫ mice restores urinary pH to control values (46) . Altogether these findings suggest that activation of calcium-sensing mechanisms by high luminal [Ca 2ϩ ] in the OMCD promotes urinary acidification and thereby prevents the formation of renal Ca 2ϩ -phosphate stones (46) . We examined this hypothesis by postulating a sigmoidal dependence of the OMCD H ϩ -ATPase flux on luminal [Ca 2ϩ ] (Eq. 4). Even when the proton flux was increased by a factor of 5 as a result, urinary pH was predicted to decrease by only 0.2 units (Fig. 9 ). These effects are small relative to experimental observations. One possible explanation is that Ca 2ϩ -induced regulation of H ϩ -ATPase activity occurs in other tubules as well, such as the CCD. The sensitivity of the pump to Ca 2ϩ may also be poorly represented by the sigmoidal dependence that we assumed. Finally, there may be significant differences between species (our model applies to the rat) and/or compensating mechanisms in TRPV5 Ϫ/Ϫ animals for which our model does not account. The finding that CaSR regulates Ca 2ϩ absorption in the TAL independently of PTH has raised the possibility that CaSR inhibitors may be used to treat disorders related to impaired PTH secretion (39) . To test this, we simulated the effects of blocking CaSR in parathyroidectomized rats (Fig.  12) . Our results suggest that CaSR inhibitors may indeed significantly reduce urinary Ca 2ϩ excretion in the absence of PTH secretion. Such inhibitors could thus be used to reduce the risk of calcium stone formation in subjects with hypoparathyroidism.
In summary, we have developed a detailed, epithelial-based model of Ca 2ϩ transport along the TAL and the distal nephron. The model predicts that renal CaSRs significantly expand the range in which Ca 2ϩ reabsorption is regulated but have a small impact on the renal handling of other solutes.
APPENDIX
In addition to incorporating the transport of Ca 2ϩ (see MODEL DESCRIPTION), the present model differs from that of Weinstein (61) in the following ways.
We distinguish between the early (DCT1) and late (DCT2) segments of the distal convoluted tubule: the DCT1 expresses Na ϩ -Cl Ϫ cotransporters (NCC) but not the epithelial Na ϩ channel (ENaC), whereas the DCT2 expresses both (38) . Along the DCT2, the density of NCC is taken to decrease linearly to zero and that of ENaC to increase from zero to its value in the CNT. The DCT1 is taken to be 0.67 mm long and the DCT2 0.33 mm long.
In both the CNT and CCD, transport across pendrin (the apical Cl Ϫ /HCO 3 Ϫ exchanger in type B cells) is represented using the kinetic model that we previously developed (3) . The density of pendrin is respectively taken as 0. 57 
